Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.39 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | STS | P08842 | 7/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.38 |
| ▸ | ELANE | P08246 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18199212 | 0.95 | TSHR (0.41) | MAPTTSHRHPGDLMNACYP1A2 | |
| SCHEMBL18199233 | 0.94 | STS (0.41) | MAPTTSHRHPGDLMNACYP1A2 | |
| SCHEMBL18199201 | 0.92 | ELANE (0.39) | MAPTTSHRHPGDLMNACYP1A2 | |
| SCHEMBL26037650 | 0.91 | MAPT (0.39) | MAPTTSHRHPGDLMNACYP1A2 | |
| SCHEMBL18199199 | 0.91 | MAPT (0.39) | MAPTTSHRHPGDLMNACYP1A2 | |
| SCHEMBL22667668 | 0.91 | TSHR (0.45) | MAPTTSHRHPGDLMNACYP1A2 | |
| SCHEMBL16675529 | 0.90 | HPGD (0.35) | MAPTTSHRHPGDALDH1A1MEN1 | |
| SCHEMBL23227557 | 0.90 | TSHR (0.41) | TSHRHPGDLMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL11917947 | 0.89 | TSHR (0.42) | TSHRHPGDSMN1; SMN2ALDH1A1KMT2A | |
| SCHEMBL22667423 | 0.89 | ELANE (0.42) | MAPTTSHRHPGDLMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230141025-A1 | SENSOR AND BAND PASS FILTER | FUJIFILM CORPORATION (JP) | 2023-05-11 | — | — | US | disclosed |
| US-20230141025-A1 | SENSOR AND BAND PASS FILTER | FUJIFILM CORPORATION (JP) | 2023-05-11 | — | — | US | disclosed |
| US-11332671-B2 | Liquid crystal composition, method for producing reflective layer, reflective layer, cured product, and optically anisotropic body | FUJIFILM CORPORATION (JP) | 2022-05-17 | — | — | US | disclosed |
| US-11209688-B2 | Reflective layer obtained by immobilizing cholesteric liquid crystalline phase | FUJIFILM CORPORATION (JP) | 2021-12-28 | — | — | US | disclosed |
| US-20200102500-A1 | LIQUID CRYSTAL COMPOSITION, METHOD FOR PRODUCING REFLECTIVE LAYER, REFLECTIVE LAYER, CURED PRODUCT, AND OPTICALLY ANISOTROPIC BODY | FUJIFILM CORPORATION (JP) | 2020-04-02 | — | — | US | disclosed |
| US-10457628-B2 | Polymerizable compound, polymerizable composition, film, and half mirror for displaying projection image | FUJIFILM CORPORATION (JP) | 2019-10-29 | — | — | US | disclosed |
| US-10323120-B2 | Polymerizable composition containing polymerizable compound, film, and half mirror for displaying projection image | FUJIFILM CORPORATION (JP) | 2019-06-18 | — | — | US | disclosed |
| US-20190033634-A1 | METHOD FOR PRODUCING REFLECTIVE LAYER AND REFLECTIVE LAYER | FUJIFILM CORPORATION (JP) | 2019-01-31 | — | — | US | disclosed |
| US-20180100103-A1 | POLYMERIZABLE COMPOSITION CONTAINING POLYMERIZABLE COMPOUND, FILM, HALF MIRROR FOR DISPLAYING PROJECTION IMAGE, AND POLYMERIZABLE COMPOUND | FUJIFILM CORPORATION (JP) | 2018-04-12 | — | — | US | disclosed |
| US-20180100103-A1 | POLYMERIZABLE COMPOSITION CONTAINING POLYMERIZABLE COMPOUND, FILM, HALF MIRROR FOR DISPLAYING PROJECTION IMAGE, AND POLYMERIZABLE COMPOUND | FUJIFILM CORPORATION (JP) | 2018-04-12 | — | — | US | disclosed |
| US-20170190821-A1 | POLYMERIZABLE COMPOSITION CONTAINING POLYMERIZABLE COMPOUND, FILM, AND HALF MIRROR FOR DISPLAYING PROJECTION IMAGE | FUJIFILM CORPORATION (JP) | 2017-07-06 | — | — | US | disclosed |
| US-20170190821-A1 | POLYMERIZABLE COMPOSITION CONTAINING POLYMERIZABLE COMPOUND, FILM, AND HALF MIRROR FOR DISPLAYING PROJECTION IMAGE | FUJIFILM CORPORATION (JP) | 2017-07-06 | — | — | US | disclosed |
| US-20160318845-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, FILM, AND HALF MIRROR FOR DISPLAYING PROJECTION IMAGE | FUJIFILM CORPORATION (JP) | 2016-11-03 | — | — | US | disclosed |
| US-20160318845-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, FILM, AND HALF MIRROR FOR DISPLAYING PROJECTION IMAGE | FUJIFILM CORPORATION (JP) | 2016-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10457628-B2 | Polymerizable compound, polymerizable composition, film, and half mirror for displaying projection image | PYM1, C5, C1S | MAPT 1478/4885TSHR 3946/4885HPGD 4486/4885 |
| US-20160318845-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, FILM, AND HALF MIRROR FOR DISPLAYING PROJECTION IMAGE | PYM1, C5, C1S | MAPT 1489/4885TSHR 3939/4885HPGD 4496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.